Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Baby Girl Free Of Breast Cancer Gene Due To Be Born Soon
http://www.medicalnewstoday.com/articles/133904.php
The first British baby girl free of the faulty BRCA 1 gene, which significantly raises a woman's chances of developing breast cancer, is due to be born soon. The girl has been genetically selected to be free of the faulty gene.
----------------------------------------------
** CANCER / ONCOLOGY News **
Phase 1 Clinical Trial Of FG-3019, Anti-Connective Tissue Growth Factor (CTGF) Investigational Therapy, In Patients With Pancreatic Cancer Launched
http://www.medicalnewstoday.com/articles/133581.php
FibroGen, Inc. has announced that an open-label, phase 1 clinical trial designed to evaluate the safety and tolerability of FG-3019, a fully human monoclonal antibody against connective tissue growth factor (CTGF), in combination with gemcitabine and erlotinib in patients with locally advanced or metastatic pancreatic cancer has commenced.
SRA Supports Groundbreaking Cancer Research
http://www.medicalnewstoday.com/articles/133432.php
SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, has announced that it collected and managed all of the research data associated with a groundbreaking brain tumor study recently released by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI).
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
INVIRION Diagnostics Launches Successful Hybrid Instrument At EUROGIN 2008
http://www.medicalnewstoday.com/articles/133551.php
INVIRION Diagnostics, LLC, successfully launched their new Molecular Hybrid Platform (MoHP) at EUROGIN 2008 (European Research Organization on Genital Infection and Neoplasia). EUROGIN is the leading international multidisciplinary organization involved in research, training, screening, prevention and information concerning genital infections, pre-cancers and cancers in women.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
FDA Approves Genzyme's Mozobil - Provides Stem Cell Mobilization For Autologous Transplantation In NHL And Multiple Myeloma Patients
http://www.medicalnewstoday.com/articles/133562.php
Genzyme Corporation (Nasdaq: GENZ) has announced that the U.S. Food and Drug Administration has granted marketing approval for Mozobil™ (plerixafor injection), a drug intended to be used in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM).
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
No news for this category today.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment